Lithium augmentation in a case of renal impairment: risk vs. benefit.
Gash
A J
AJ
Palmer Community Hospital, Jarrow, Tyne and Wear, UK.
Chhabra
S
S
Eccleston
D
D
D000368:Aged; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced / Q000503:physiopathology*; D007677:Kidney Function Tests; D016651:Lithium Carbonate / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D012307:Risk Factors
D000928:Antidepressive Agents; D016651:Lithium Carbonate